Capricor sues Nippon Shinyaku over Duchenne drug ‘pricing flaw’ and launch prepnews2026-05-08T11:00:19+00:00May 8th, 2026|Endpoints News|
Supreme Court restores mifepristone access by mailnews2026-05-04T16:14:14+00:00May 4th, 2026|Endpoints News|
Court dismisses part of Lilly lawsuit against Empower, some claims can proceednews2026-04-30T18:16:20+00:00April 30th, 2026|Endpoints News|
Supreme Court questions how far generics makers can go with ‘skinny label’ drugsnews2026-04-30T18:10:37+00:00April 30th, 2026|Endpoints News|
Pfizer delays patent cliff for blockbuster Vyndamaxnews2026-04-28T17:36:36+00:00April 28th, 2026|Endpoints News|
Hikma and Amarin’s generic drug case heads to Supreme Court argumentsnews2026-04-28T17:14:57+00:00April 28th, 2026|Endpoints News|
Erasca reports RAS cancer drug data after legal threat from Revolutionnews2026-04-27T20:01:10+00:00April 27th, 2026|Endpoints News|
Revolution Medicines threatens to sue Erasca over patent, efficacy claimsnews2026-04-27T18:17:42+00:00April 27th, 2026|Endpoints News|
Utah doctors demand suspension of Doctronic AI programnews2026-04-27T17:42:11+00:00April 27th, 2026|Endpoints News|
Pharma-backed petition calls on FDA to reform release of drug rejection lettersnews2026-04-22T16:14:47+00:00April 22nd, 2026|Endpoints News|
